#USA #Boston #Takeda #AI Program #TetraScience

TetraScience Launches Scientific AI Lighthouse Program

TetraScience, a leader in scientific data and artificial intelligence, has unveiled its ambitious Scientific AI Lighthouse (SAIL) program, marking a significant step forward in the biopharmaceutical sector. Partnering with Takeda, a global biopharmaceutical company, this initiative is set to redefine the landscape of drug discovery and research by harnessing the power of AI.

A New Era in Biopharma Research

The SAIL program aims to address long-standing challenges within the pharma research and development sphere. For decades, productivity in this area has been hindered by fragmented data, manual processes, and bespoke project approaches that lack scalability. With SAIL, TetraScience presents a fully integrated suite of features designed to confront these challenges head-on, transforming the way biopharma companies operate.

Key Features of the SAIL Program

1. Scientific Data Foundry: This feature breaks down scientific data collected in proprietary silos into atomic units such as experimental measurements and derived results. By organizing this data into AI-native schemas and taxonomies, the Foundry enhances data reusability and compliance, making it resilient against vendor lock-in.

2. Scientific Use Case Factory: This component focuses on the mass production of AI-enabled use cases and workflows. By combining AI-native data from the Foundry, the Factory creates standard, repeatable, and configurable processes that can be deployed across the biopharma industry.

3. Tetra AI: Offering both semi-autonomous and fully autonomous agent functionalities, Tetra AI aids scientists in navigating complex research processes. The AI identifies and delivers pertinent data from various experiments, unearthing patterns often missed by manual analysis, ultimately speeding up decision-making.

4. Sciborgs: TetraScience employs interdisciplinary teams known as Sciborgs—composed of scientists and engineers—who work at the intersection of science, data, and AI. These teams help facilitate successful implementation and change management, ensuring that the adoption of Scientific AI is both sustainable and effective.

Revolutionizing Productivity and Innovation

The integration of AI and digital technologies across the research and development chain is poised to become one of Takeda's pivotal strategies for future growth. According to Nicole Glazer, head of FE Data, Digital and Technology at Takeda, the data-driven approach enabled by this partnership will expedite discovery timelines, enhance target identification, and facilitate the creation of better therapeutic candidates.

Jim Villa, Takeda's global head of research strategy, emphasized that by reinventing how scientists access, analyze, and share research data, they unlock new levels of productivity and foster AI-driven insights through a connected online environment.

Tackling Eroom's Law

During his presentation, Patrick Grady, CEO of TetraScience, poignantly mentioned the pharmaceutical industry's struggle with Eroom's Law, which observes that drug development costs double approximately every nine years. TetraScience aims to shift the industry away from non-scalable, customized data projects toward productive, industrialized, AI-native scientific data and workflows. This transition could potentially reverse the trajectory dictated by Eroom's Law, accelerating discovery and minimizing development cycle times.

Conclusion

In summary, TetraScience’s SAIL program represents a landmark effort to reshape scientific research for the age of AI. Through its partnership with Takeda, it seeks not only to enhance productivity but also to drive innovation by leveraging data and agent-based AI to integrate information more rapidly, uncover new connections, and formulate better hypotheses in drug research. As the program evolves, it stands to potentially revolutionize the future of pharmaceutical development and research, making significant strides in both speed and quality of drug discovery processes. For more information, visit TetraScience.